[Radioactive strontium for treating incurable pain in skeletal neoplasms (author's transl)].
D000135:Acid Phosphatase; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase; D001859:Bone Neoplasms / Q000150:complications*; D001862:Bone Resorption; D001943:Breast Neoplasms / Q000150:complications; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009068:Movement / Q000187:drug effects; D009101:Multiple Myeloma / Q000150:complications; D009362:Neoplasm Metastasis; D010148:Intractable Pain / Q000209:etiology / Q000532:radiotherapy*; D011877:Radionuclide Imaging; D012075:Remission, Spontaneous; D013326:Strontium Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000150:complications; D014594:Uterine Neoplasms / Q000150:complications
D013326:Strontium Radioisotopes; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase
Neue Methode zur Behandlung inkurabler Schmerzzustände bei neoplastischer ossärer Infiltration.